HM12460A

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HM12460A, covering 2017-11-08 to 2017-11-08. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A [Phase 1]

See pricing